ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study
To access this article, please choose from the options below
The TRAIN study was funded by the National Institutes of Health (NIH grant R01-HL68901). The TRAIN study was also (partially) supported by the University of Florida Claude D. Pepper Older Americans Independence Center (NIH grant 1P30-AG028740), Wake Forest University Claude D. Pepper Older Americans Independence Center (NIH grant 5P30-AG021332), and the Wake Forest University General Clinical Research Center (NIH grant M01-RR07122). Fosinopril was donated by Bristol-Myers Squibb (New York, NY).
PII: S1525-8610(09)00347-8
doi:10.1016/j.jamda.2009.09.014
© 2010 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
